Gastroenterology / Antibiotic
Rifadoxy 550
Rifaximin IP 550 mg
B2B catalogue entry for a tablet listed with rifaximin IP 550 mg, presented for qualified documentation, classification, and trade inquiries.
AntibioticB2B catalogue entry
Rifadoxy 400
Rifaximin IP 400 mg
B2B catalogue entry for a tablet listed with rifaximin IP 400 mg, presented for qualified documentation, classification, and trade inquiries.
Product gallery
Select an image to preview
1/4
Catalogue information
Product fields for initial trade review
View fieldsHide fields
Catalogue information
Product fields for initial trade review
- Catalogue name
- Rifadoxy 400
- Composition as listed
- Rifaximin IP 400 mg
- Dosage form as listed
- Tablet
- Commercial pack as listed
- 10 x 10 Tablets
- Catalogue category
- Antibiotic
- Portfolio division
- Gastroenterology
- Listing organization
- Medoxy Healthcare Pvt Ltd
- Handling reference
- Request current product-specific storage and transport conditions
Catalogue data supports initial B2B identification only. Confirm every field against current, applicable product, market, and quality records before relying on it.
B2B catalogue verification
Verify the record for Rifadoxy 400
Reconcile this online entry with current, applicable documents before a purchasing, listing, or supply decision.
Catalogue record
For identification only; not a controlled specification.
- Catalogue name
- Rifadoxy 400
- Composition as listed
- Rifaximin IP 400 mg
- Dosage form as listed
- Tablet
- Commercial pack as listed
- 10 x 10 Tablets
- Catalogue category
- Antibiotic
- Portfolio division
- Gastroenterology
Request before review
Confirm applicability and disclosure conditions for each requested record.
- Current label or artwork and applicable market authorization or classification records
- Pack identifiers and product-specific storage and transport instructions from controlled documents
- Relevant product- or batch-level quality records and the complaint, recall, and change-notification contact
Official context
General references only; neither confirms this product's authorization or quality status.
Information boundary
This B2B catalogue entry is not patient guidance or prescribing information. It provides no indication, dose, administration, safety, storage, or availability advice. Use current approved product information and applicable records for professional purchasing and supply review.
Related Products
Related Gastroenterology catalogue entries
Gastroenterology / Antispasmodic
Benzispa SR
Mebeverine Hydrochloride Sustained Release
B2B catalogue entry for a sustained-release capsule listed with mebeverine hydrochloride; qualified buyers may request current product and market documents, subject to applicability and availability.
Gastroenterology / Antispasmodic
Benzispa Plus
Mebeverine + Chlordiazepoxide
B2B catalogue entry for a tablet listed with mebeverine and chlordiazepoxide, presented for qualified product-document and trade inquiries.
Gastroenterology / Acidity & GERD
Esomizole-D
Esomeprazole (EC) + Domperidone (SR)
B2B catalogue entry for a capsule listed with enteric-coated esomeprazole and sustained-release domperidone, subject to document and market review.
Request Information
Ask about applicable product documents
Tell us your organization, destination market, and the decision your request supports so applicability can be reviewed.